The KRASG12C inhibitors in lung cancer therapy

• Principais autores: Maciej Jędrak (Autor), Karolina Niekurzak (Autor), Joanna Kania (Autor), Maciej Józefiak (Autor), Piotr Sobkiewicz (Autor), Krzysztof Kania (Autor)
• Formato: Livro
• Publicado em: Kazimierz Wielki University, 2023-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutation...